vimarsana.com

The global PD L1 biomarker testing market is expected to touch US$ 14.2 billion by 2030, with an annual growth rate of more than 16.5% says RationalStatWilmington, Delaware, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Global PD L1 Biomarker Testing Market is valued at US$ 4.9 billion in 2023 and is expected to grow at a significant CAGR of over 16.5% over the forecast period of 2023-2030, according to the published market report by RationalStat Market Definition, Market Scope, and Report Overview Programm

Related Keywords

Mexico ,United States ,South Korea ,Brazil ,United Arab Emirates ,France ,Hungary ,Thailand ,Nigeria ,Poland ,Canada ,Saudi Arabia ,South Africa ,China ,Indonesia ,Australia ,United Kingdom ,India ,Spain ,Malaysia ,Japan ,Russia ,Philippines ,Italy ,Turkey ,Delaware ,Germany ,Vietnam ,Republic Of ,America ,Asia Pacific ,Leica Biosystems ,Bristol Myers Squibb ,Kimberly Shaw ,Research Methodology ,Astrazeneca ,Abbott Laboratories ,Year Market ,Genentech ,Market Scope ,North America ,Latin America ,Western Europe ,Eastern Europe ,Middle East ,Production Levels ,Capacity Utilization ,Testing Market ,Market Share ,Market Structure ,Thermo Fisher Scientific ,Bio Rad Laboratories ,Testingmarket Value ,Testing Market Value ,Arab Emirates ,Questions Answered ,Testing Report ,Key Insights ,Market Data ,Kingdom Phone ,Market Intelligence ,Market Sizing ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.